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surface for in vivo skin dosimetry. The advantages of the MOSkin detector are its water equivalent depth 
of measurement of 0.07 mm, small physical size with submicron dosimetric volume, and the ability to 
provide real-time readout. A MOSkin detector was calibrated and the reproducibility, linearity, and 
response over a large dose range to different threshold voltages were determined. Surface dose on solid 
water phantom was measured using MOSkin detector and compared with Markus ionization chamber and 
GAFCHROMIC EBT2 film measurements. Dependence in the response of the MOSkin detector on the 
surface of solid water phantom was also tested for different (i) source to surface distances (SSDs); (ii) 
field sizes; (iii) surface dose; (iv) radiation incident angles; and (v) wedges. The MOSkin detector showed 
excellent reproducibility and linearity for dose range of 50 cGy to 300 cGy. The MOSkin detector showed 
reliable response to different SSDs, field sizes, surface, radiation incident angles, and wedges. The 
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In vivo dosimetry is important during radiotherapy to ensure the accuracy of the 
dose delivered to the treatment volume. A dosimeter should be characterized 
based on its application before it is used for in vivo dosimetry. In this study, we 
characterize a new MOSFET-based detector, the MOSkin detector, on surface 
for in vivo skin dosimetry. The advantages of the MOSkin detector are its water 
equivalent depth of measurement of 0.07 mm, small physical size with submi-
cron dosimetric volume, and the ability to provide real-time readout. A MOSkin 
detector was calibrated and the reproducibility, linearity, and response over a 
large dose range to different threshold voltages were determined. Surface dose 
on solid water phantom was measured using MOSkin detector and compared 
with Markus ionization chamber and GAFCHROMIC EBT2 film measurements. 
Dependence in the response of the MOSkin detector on the surface of solid water 
phantom was also tested for different (i) source to surface distances (SSDs);  
(ii) field sizes; (iii) surface dose; (iv) radiation incident angles; and (v) wedges. 
The MOSkin detector showed excellent reproducibility and linearity for dose range 
of 50 cGy to 300 cGy. The MOSkin detector showed reliable response to different 
SSDs, field sizes, surface, radiation incident angles, and wedges. The MOSkin 
detector is suitable for in vivo skin dosimetry. 
PACS number: 87.55.Qr




Quality assurance (QA) in radiotherapy is very important in order to ensure the correct function-
ing of all components in radiotherapy, from treatment planning to the delivery of the treatment.(1) 
Nowadays, advanced radiotherapy techniques, such as intensity-modulated radiotherapy (IMRT), 
require patient-specific QA to be performed to ensure the accuracy of radiation delivery during 
radiotherapy. However, these QA and verification procedures may not be sufficient to ensure 
the accuracy of the entire radiotherapy treatment. 
A number of incidents have been reported recently.(2-4) Human errors and systematic errors 
contributed to these incidents. Therefore, towards that end, in vivo dosimetry can detect 
major errors during the delivery of radiotherapy. It also can access clinical relevant differ-
ences between planned and delivered dose, record the dose received by the patient, and fulfill 
legal requirements.(1)
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In radiotherapy, in vivo dosimetry means the measurement of the radiation dose received by 
a patient during treatment.(1) Ideally, a dosimeter should be positioned at the point of interest 
inside a patient’s body. However, in many cases it is not possible to place a dosimeter inside 
a real patient’s body. Hence, the placement of a dosimeter on the surface of the patient’s body 
becomes an alternative. 
An ideal in vivo dosimeter should possess the following characteristics: (i) tissue equivalent; 
(ii) small in physical size and has small sensitive volume; (iii) features (e.g., temperature, energy) 
which are consistent and characterizable; (iv) does not perturb the radiation field; (v) nonhazard-
ous to humans; and (vi) able to provide real-time dosimetric information. Thermoluminescence 
dosimeter (TLD)(5-7) is small in size, but requires a long series of pre- and postirradiation 
process. Radiochromic film(8-10) has excellent dosimetric spatial resolution, is able to provide 
two-dimensional (2D) dosimetric information(11) and is easy to use, but it is not done in real-time 
and may be affected by improper handling and scanner performance. Semiconductor detec-
tors such as diode(12-13) and metal oxide semiconductor field effect transistor (MOSFET)(14-19) 
are able to achieve excellent spatial resolution with their small sensitive volumes. However, 
the energy, angle, temperature, and dose-rate dependence of semiconductor detectors require 
rigorous characterization.
The dose deposited on a phantom or patient surface mainly comes from primary photon 
beam, backscattered radiation from the phantom, as well as radiation contamination from the 
accelerator. Radiation contamination arises from: (i) treatment head materials and (ii) treatment 
setup parameters such as source-to-surface distance (SSD), field size, and beam modifier to the 
surface dose.(20) These contaminations will affect the dose in the buildup region. Therefore, it 
is essential to determine and know the effect of these treatment parameters.
Different terminologies, such as surface dose, skin dose, and entrance dose, have been used 
to describe the dose measured on the surface of a phantom or a human. The definitions for these 
terminologies differ according to the point of measurement on the patient or phantom. Surface 
dose is defined as the dose on the surface of the phantom or human, which is the interface between 
the air and the surface. Skin dose is defined as the dose at the depth of 0.07 mm.(21) Entrance 
dose is defined as the dose given by the entrance beam at the depth of maximum dose.(22)
Characterization of a dosimeter is normally performed at a condition where charged particle 
equilibrium (CPE) condition exists.(12-13,19) However, for in vivo skin dosimetry, the dosimeter 
should be characterized on the surface instead of the depth of maximum dose. This is because 
the dosimetric condition of skin surface and buildup region is different from the dosimetric 
condition at the depth of maximum dose. At the interface of two media (air and human tissue), 
CPE does not exist and there is a steep dose gradient in the buildup region. Therefore, charac-
terization of a dosimeter on surface is needed prior to using it for in vivo skin dosimetry.
A MOSFET-based dosimeter, the MOSkin detector was designed and prototyped by the 
Center for Medical Radiation Physics (CMRP) in the University of Wollongong (UoW). The 
advantages of the MOSkin detector, such as being small in size with submicron dosimetric 
volume which provides excellent dosimetry spatial resolution, as well as the ability to provide 
real-time reading and instant readout, make it suitable for in vivo skin dosimetry measurement. 
The MOSkin detector has been characterized and been used for dose measurement in megavolt-
age radiotherapy and brachytherapy.(23-30)
In this paper, a full characterization of the MOSkin detector on the surface of a phantom 
simulating the actual condition for in vivo skin dosimetry (where non-CPE condition exist) 
was performed and reported. These include: (i) detector calibration, linearity, reproducibility; 
(ii) source to surface distance dependence; (iii) field size dependence; (iv) surface dose mea-
surement; (v) angular dependence; and (vi) wedge response. Comparison and verifications 
were made with previous works with some extension, while benchmarking against different 
dosimeters that are available commercially and used extensively in radiotherapy centers.
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II. MAtErIALS And MEtHOdS
A.  the MOSkin detector
The MOSkin system is shown in Fig. 1. The MOSkin detector is composed of hermetically sealed 
MOSFET dye with submicron thickness of the sensitive volume into Kapton pigtail strip with 
thickness of 0.55 mm using “drop-in” packaging technology(31) (Fig. 1(a)). The thin reproducible 
polyamide film acts as an electrical connection and buildup for MOSkin, and gives a water-
equivalent depth (WED) of approximately 0.07 mm in tissue, making it a suitable dosimeter 
for skin dose measurement.(24) According to the International Commission on Radiological 
Protection (ICRP) publication,(21) the most radiosensitive layer of epidermis is located at tissue 
depth of approximately 0.07 mm. A detailed description of the MOSkin dosimetry system can 
be found in Kwan et al.(24) and Qi et al.(26) The readout process of MOSkin detector requires 
measurement of the voltage across the gate of the MOSkin detector under condition of the 
constant source–drain current that is called the threshold voltage, Vth. The Vth increases with 
accumulated radiation dose. The readout current corresponds to the thermostable point of the 
MOSFET to avoid errors associated with thermal instability of the Vth. The sensitivity of the 
MOSkin detector is defined as the shift of the Vth with the absorption of 1 cGy of radiation 
dose (Eq. (1)). In this work, the MOSkin measurements were benchmarked against Markus 
ionization chamber (Markus type 23343 parallel plate ionization chamber; PTW, Freiburg, 
Germany) and/or GAFCHROMIC EBT2 film (International Specialty Products, Wayne, NJ). 
All measurements were carried out three times and the mean ± 1 SD of the readings were 
reported unless stated otherwise. 
                                                                                        (1)
 
where ΔVth is the change of the threshold voltage in unit Volt (V).
Fig. 1. MOSkin system, MOSkin detector (top right), and the schematic diagram of MOSkin detector in (a) face-up and 
(b) face-down orientation.
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B.  GAFCHROMIC EBT2 film preparation
GAFCHROMIC EBT2 films were cut into sizes of 1.5 × 1.5 cm². They were scanned using a 
flatbed scanner (Epson 10000XL scanner; Epson America, Inc. Long Beach, CA) 24 hours after 
irradiation to allow for postirradiation color changes.(32) The films were scanned in a reflection 
mode, at a resolution of 96 dots per inch (dpi), 48-bits RGB format, and analyzed using ImageJ 
1.46r software (National Institute of Health, Bethesda, MD). Care was taken to scan the films at 
the center of the scanner to avoid scanner-induced nonuniformity. The films were also scanned 
in the same orientation to avoid film-induced changes in pixel values.(33) Only the red channel 
was used for analysis. A region of interest (ROI) was selected at the center of the film. A set of 
standard films was irradiated to establish the calibration curve. 
C.  detector characterization
C.1 Calibration, linearity, and reproducibility 
The MOSkin detectors were calibrated under a Varian Clinac 2100 C/D accelerator (Varian 
Medical System, Palo Alto, CA) using 6 MV photon beam under standard conditions (1.5 cm 
depth in 30 × 30 × 15 cm³ solid water phantom, 100 cm source–surface distance (SSD), and 
10 × 10 cm² field size). Sensitivities of the MOSkin detector have been determined. Linearity 
measurement of the MOSkin detector was determined for a dose range of 50 cGy to 300 cGy, 
with an increment of 50 cGy, and the reproducibility was assessed. 
In this work, the buildup cap for the Markus ionization chamber was removed in order to 
position the chamber’s effective measurement closer to the surface. Temperature and pressure 
correction factor, polarity effect correction factor, and ionization recombination correction factor 
were taken into account for Markus ionization chamber measurements. Parallel plate ionization 
chambers (Markus ionization chamber) are known to overrespond due to side scatter from the 
chamber’s wall.(34-36) In this work, Gerbi and Khan’s correction(36) (Eqs. (2) and (3)) was only 
applied in the surface dose measurement (Material & Methods section C.4). 
  (2)
  (3)
where, P′(d,E) is the corrected PDD, P(d,E) is the measured PDD, E is the energy, l is the plate 
separation (2 mm for Markus PTW 23343), α is constant (5.5), C is the sidewall collector dis-
tance (0.35 mm for Markus PTW 23343), IR is the ionization ratio, and d is the depth of the 
chamber front window below the surface of phantom surface. The calculated ε(d,E) are 10.14 
and 6.89 for 6 MV and 10 MV photon beams, respectively.
Except for calibration and dose linearity measurement, all measurements were carried out 
on the surface of a solid water phantom. Characterization was carried out using a 30 × 30 × 15 
cm³ solid water phantom with a 6 MV photon beam, 100 cm SSD, and 10 × 10 cm² field size 
(Fig. 2), unless stated otherwise. This setup is henceforth called the “standard surface setup”.
Cheung et al.(37) has studied the temperature dependence of this MOSFET-based detector. 
They reported that this detector shows a variation of 50 mV over the temperature range from 
20°–40°C. This variation is corresponding to about 10 cGy in dose. However, in order to get 
an accurate reading, the detector should be placed on phantom or patient approximately 60 s 
before measurement, to allow thermal equilibrium, and the reading are taken whilst the detector 
remains on the phantom or patient. The same precaution was also taken throughout this work 
to reduce the effect of temperature dependence of the detector.
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C.2 Source-to-surface distance dependence 
The MOSkin detector was positioned as per the “standard surface setup”. The response of the 
MOSkin detector for different distances from the source was measured with SSD, varying 
from 80 cm to 110 cm with 5 cm increments. One hundred MUs were delivered for each and 
repeated twice for all measured SSDs. Dose-rate dependence of the MOSkin detector was also 
evaluated in this section. The dose rate at dmax was calculated.
C.3 Field size dependence 
The MOSkin detector was set up per “standard surface setup” and irradiated with different field 
sizes from 1 × 1 cm² to 40 × 40 cm² using 6 MV photon beam. 
C.4 Surface dose measurement 
The surface dose measured by MOSkin detector for 6 MV and 10 MV photon beams was 
evaluated. The measured dose by Markus ionization chamber was corrected, based on Gerbi 
and Khan’s formulae.(36)
C.5 Angular dependence 
Conventionally, angular dependence of the MOSFET was carried out at a depth where the CPE 
condition exists. Kwan et al.(24) and Qi et al.(29) have measured angular dependence of ± 2% for 
MOSkin detector in a cylindrical phantom, where the CPE exists, and Qi et al.(26) have measured 
angular dependence of 3.1% on the surface of a solid water phantom. As reported in Scalchi 
et al.,(17) full buildup setup where CPE exists gives better results than a surface setup. 
Here we study the angular response of MOSkin detector placed on the surface of a phantom 
as the detector will be used for in vivo skin dose measurement where CPE does not exist. It is 
important to note that surface dose increases with beam incidence angle and correct measure-
ments of the surface dose or skin dose for different angles of beam incidence are valuable for 
treatment planning system (TPS) verification. In particular, for the case of tangential beams, the 
angular response of the MOSkin detector will consist of the increased surface dose due to the 
beam incident angle and the intrinsic angular response of the MOSkin. The angular response 
of the MOSkin detector was assessed in face-up and face-down orientation, as shown in Figs. 
1(a) and (b), by positioning the MOSkin detector per “standard surface setup”. One hundred 
Fig. 2. Schematic diagram of the standard setup of characterization of MOSkin detector on the surface of a solid 
water phantom.
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MUs of 6 MV photon were delivered with the accelerator gantry rotated to the angles of 0° to 
75°, with 15° increments.
C.6 Wedge response 
In some clinical applications, such as conventional breast radiotherapy, beam modifier devices 
like physical wedge (PW) or dynamic wedge (DW)(38-39) may be required to tilt the dose profile, 
resulting in an angled isodose curve.(38) Beam quality and dose rate of the incident photons 
may change due to the presence of the beam modifier device.(40) For wedge response measure-
ment, the MOSkin detector was irradiated using “standard surface setup”. One hundred MUs 
were delivered on the detector in an open field and subsequently with the application of PW 
and DW of 15°, 30°, 45°, and 60°. 
 
III. rESuLtS & dISCuSSIOn 
A.  Calibration, linearity and reproducibility 
The MOSkin detector showed excellent reproducibility with deviation of less than 1% and 
excellent linearity (R² = 0.997) for the dose range of 0 cGy to 300 cGy, as shown in Fig. 3. The 
reproducibility of the MOSkin detector was determined based on the average standard deviation 
(1 SD) of three repeated measurements of each dose level in linearity test. The dose linearity 
verification was carried out at this range because it was deemed to be within the range of a 
normal fractionated dose in radiotherapy. The average sensitivity of the MOSkin detectors in this 
study was 2.53 ± 0.03 mV/cGy for 6 MV photon beam. The sensitivity of the MOSkin detector 
as a function of cumulative dose was found to decrease by 9 × 10-2 mV/cGy for every 10 Gy 
of delivered dose (Fig. 4). The sensitivity of the MOSkin detectors is expected to decrease as 
the cumulative dose increases.(41) Therefore, it is recommended that periodic recalibration be 
carried out throughout the detector’s useful lifetime based on the accuracy needed. The readers 
are referred to Qi et al.(23) for details of the MOSkin detector’s lifetime. 
Fig. 3. Linearity of MOSkin detector for the dose range of 0 cGy to 300 cGy.
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B.  Source-to-surface distance dependence
Results of SSD dependence and dose rate dependence measurements for Markus ionization 
chamber, GAFCHROMIC EBT2 film, and the MOSkin detector are presented in Fig. 5. All 
measured doses were corrected with inverse square correction factor (ISCF) and normalized 
to the corrected dose at SSD 100 cm. An ideal SSD independent and dose rate independent 
dosimeter will have an “Inverse Square Corrected Relative Dose” equal to one. 
From Fig. 5, the MOSkin detector, GAFCHROMIC EBT2 film, and Markus ionization 
chamber showed steady response over 80 cm to 110 cm SSD. The average variation of all 
SSDs for the MOSkin detector, GAFCHROMIC EBT2 film, and Markus ionization chamber 
was 0.1%, 1.0%, and 0.5%, respectively. 
On the surface of the phantom, the dose deposited is not only due to the primary beam directed 
from the treatment head, but also from the contaminant electrons which are generated outside 
of the patient in the air and collimator. This may contribute to the SSD dependence of a skin 
dosimeter. This contamination is not sufficient to contribute to SSD dependence for large SSD 
as the electrons produced in the accelerator were of relatively high energy.(20) Measurements 
at shorter SSD exposed the dosimeter to large amounts of low-energy  photons scattered by the 
components in the accelerator and would induce a slight over-response of a dosimeter.
Fig. 4. Change in sensitivity of MOSkin detector as a function of cumulative dose.
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C. Field size dependence 
Qi et al.(26) have also studied the field size dependence of the MOSkin detector on phantom 
surface for the field size of 5 × 5 cm2 to 30 × 30 cm2. In this study, the field sizes investigated 
were extended to include small field sizes of as small as 1 × 1 cm2 and larger field size of 40 × 
40 cm2. The field size dependence of surface dose measured by MOSkin detector, as well as 
EBT2 film and Markus ionization chamber, is shown in Fig. 6. All readings were normalized 
to 10 × 10 cm² field size. The three detectors showed an upward trend as field size increases. 
This is expected and is due to the increase in the backscattered radiation from the phantom and 
radiation contamination. The radiation contamination was mainly due to the scattered radia-
tion from the flattening filter, with a small portion of scattered radiation as a function of field 
size.(42) The result of MOSkin detector and Attix ionization chamber from Qi et al.(26) are also 
presented in Fig. 6 for comparison. Surface dose increases measured with the MOSkin detec-
tors rose from 0.36 to 2.32 times of the surface dose measurement at 10 × 10 cm² for the field 
sizes from 1 × 1 cm² to 40 × 40 cm².
The dose deposited on the surface of the phantom is expected to be only 10%–20% of the 
maximum dose (Dmax).
(38) As field size increases, the surface dose increases and, hence, there 
is a corresponding reduction in the surface dose gradient.(17) 
All detectors measured increasing surface dose with increasing field size. For field size < 25 × 
25 cm2, the MOSkin measurements are in good agreement with EBT2 film. MOSkin detector 
is advantageous for small field surface dosimetry compared to Markus ionization chamber due 
to the small sensitive volume of the detector. For field size > 25 × 25 cm2, MOSkin detector 
and Markus ionization chamber measurements showed an enhanced response, compared to the 
GAFCHROMIC EBT2 film. This may be due to the side scattering effect of Markus ionization 
chamber and energy dependence of the semiconductor (MOSkin) detector. 
Good agreement between the MOSkin detector’s response and Attix ionization chamber(29) 
(average difference of 2%) has been observed due to close WED of the detectors used. Earlier 
reported results of field dependence measured with MOSkin detectors are in agreement (aver-
age difference of 3%) with presented results, confirming good reproducibility of WED of the 
MOSkin detectors.(26)
Fig. 5. SSD and dose rate response of Markus ionization chamber, GAFCHROMIC EBT2 film and MOSkin detec-
tor corrected with ISCF and normalized to the response at 100 cm SSD. The error bar represents 1 SD of three sets of 
measurements.
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d.  Surface dose measurement
The average sensitivity of the MOSkin detectors was found to be 2.53 ± 0.03 mV/cGy and 
2.50 ± 0.02 mV/cGy for 6 MV and 10 MV photon beams, respectively. The MOSkin detectors 
were 1.01% more sensitive in 6 MV photon beam compared to 10 MV photon beam. 
Table 1 shows the measured surface dose of the MOSkin detector, GAFCHROMIC EBT2 
film, and the Markus ionization chamber measurement for 6 MV and 10 MV photon beams. 
The surface doses for 6 MV photon measured by these detectors are higher than 10 MV photon 
due to the skin sparing effect of 10 MV photon.
Markus ionization chamber measured lowest surface doses for 6 MV and 10 MV photons, 
followed by the MOSkin detector and GAFCHROMIC EBT2 film. This can be explained by the 
WED of these detectors. Markus ionization chamber was assumed to have WED of 0 mm after 
the application of Gerbi and Khan’s correction.(36) MOSkin detector has a WED of 0.070 mm(24) 
and GAFCHROMIC EBT2 film has a WED of 0.122 mm. The WED of GAFCHROMIC EBT2 
film was determined based on the physical depth and density(43-44) from the surface to the center 
of the active layer.
In measuring the surface dose at the depth of 0 cm, the dose difference (%) between the 
MOSkin detector and Markus ionization chamber was found to be 4.44% and 1.74% for 6 MV 
and 10 MV photon beams, respectively (Table 1). It is expected because the dose gradient in 
build-up region for 6 MV photon beam is steeper than that of 10 MV photon beam.
Fig. 6. Field size response of the surface dose measured by MOSkin detector, GAFCHROMIC EBT2 film, and Markus 
ionization chamber normalized to response at 10 × 10 cm² radiation field size. The average standard deviation of three 
sets of measurements for MOSkin detector, GAFCHROMIC EBT2 film, and Markus ionization chamber is 0.034, 0.052, 
and 0.001, respectively.
Table 1. Comparison of the surface dose (normalized to 100% the dose at dmax) with Markus ionization chamber, 
GAFCHROMIC EBT2 film, and MOSkin detector for 6 MV and 10 MV photons. 
 Energy Markus EBT2 MOSkin
 (MV) (%) (%) (%)
 6 15.83 ± 0.03 23.01 ± 0.07 20.27 ± 0.03
 10 11.82 ± 0.00 17.89 ± 0.04 13.55 ± 0.04
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E.  Angular dependence 
Figure 7 shows the results of the measured doses which have been normalized to the dose at 
0° beam incident angle. The result of MOSkin detector and Attix ionization chamber from Qi 
et al.(26) are also presented in Fig. 7 for comparison. As the beam incident angle increases, the 
measured surface dose increases because the region of charged particle equilibrium shifts toward 
the surface. This is in agreement with the results by Scalchi et al.(17) and Qi et al.(26) 
GAFCHROMIC EBT2 film, with its dosimetric properties of tissue equivalence and homo-
geneous material, is assumed to be of angular independence. Suchowerska et al.(45) reported that 
GAFCHROMIC film shows intrinsic angular dependence of less than 1% when a measurement 
with the film surface is parallel and perpendicular to the beam direction. MOSkin detector in the 
face-up orientation showed similar angular response trend to the GAFCHROMIC EBT2 film 
(Fig. 7). GAFCHROMIC EBT2 film measured higher dose as compared to MOSkin detector 
in face-up orientation. This may be due to the difference of the WED these detectors (Results 
& Discussion section D). 
When the MOSkin detector was used in the face-down orientation for surface dose mea-
surement, it showed a trend of overresponse when compared with MOSkin detector and 
GAFCHROMIC EBT2 film. Deviation between MOSkin detector in face-up orientation and 
face-down orientation is seen to be increasing as the beam incident angle increases. Maximum 
deviation of 18.5% was found at beam incident angle of 75°. The observed angular dependence 
between MOSkin detector in the face-up orientation and face-down orientation arises from the 
effect of the difference in the WED of the detector related to the asymmetric geometry of the 
detector (inherent anisotropy). For face-down geometry, the WED is approximately 0.9 mm 
due to a 0.4 mm silicon substrate. Therefore, it is very important to identify the orientation of 
MOSkin detector when it is used for surface dose measurement. For WED 0.07 mm, MOSkin 
detector should be used in a face-up mode. Present result was in good agreement with earlier 
reported result(26) with maximum deviation of 2.2 % at angle 30°.
Fig. 7. Relative surface dose measured with GAFCHROMIC EBT2 film and MOSkin detector as the function of beam 
incident angle and normalized to 1 at 0° beam incident angle with 10 × 10 cm² field size. The error bar represents 1 SD 
of three sets of measurements. The average standard deviation of three sets of measurements for MOSkin detector and 
GAFCHROMIC EBT2 film is 0.033 and 0.036, respectively.
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F.  Wedge response 
The results of the wedge effect are summarized in Fig. 8. The doses were normalized to the 
dose measured with open field. The surface dose decreases as the wedge angle increases for 
both PW and DW. The average variation of MOSkin measurement with Markus ionization 
measurement for PW and DW was -5.5% and 5.1%, respectively. MOSkin measurement is in 
close agreement with GAFCHROMIC EBT2 film measurement. GAFCHROMIC EBT2 film 
responded higher for PW (2.8%) and DW (1.7%), respectively. This is in agreement with other 
scenarios of surface dose measurements due to higher WED of GAFCHROMIC EBT2 film in 
comparison with the MOSkin detector. 
The presence of any materials between the radiation source and the phantom or patient will alter 
the dose to the build-up region. In this work, constant MU (100 MUs) was given. The presence 
of physical wedge under the photon beam will harden the photon beam by absorbing scattered 
radiation.(38) The presence of the wedge will also produce low energy scattered radiation.(46) 
 
IV. COnCLuSIOnS
The surface dose measured with MOSkin detector was investigated on a phantom surface for 
different SSD, field sizes, surface dose, oblique beams, machine dose rates, and in the presence 
of the wedge in comparison with EBT2 film and Markus ionization chamber. 
MOSkin detector showed deviation of less than 2% over a change of 80  – 110 cm SSD. For 
field size dependence, they are in agreement with Attix ionization chamber.(29) Surface dose 
measured with the MOSkin detectors increases from 0.36 to 2.32 times of the surface dose 
measurement at 10 × 10 cm² for the field sizes from 1 × 1 cm² to 40 × 40 cm². The dose dif-
ference between the MOSkin detector and Markus ionization chamber was 4.44% and 1.74% 
for 6 MV and 10 MV photon beams, respectively. This is due to the different WEDs for both 
detectors. The dose gradient in the buildup region of 6 MV photon beam is steeper than that 
of the 10 MV photon beam. When oblique beams are used, surface dose measured with the 
MOSkin detector increases up to 1.95 times of the normal beam incidence. For angular depen-
dence, MOSkin detector in face-up orientation is in agreement with Attix ionization chamber.(26) 
Fig. 8. Wedges response measurement of Markus ionization chamber, GAFCHROMIC EBT2 film, and MOSkin detec-
tor and normalized to 1 at open field. The error bar represents 1 SD of three sets of measurements. The average standard 
deviation of three sets of measurements for MOSkin detector, GAFCHROMIC EBT2 film, and Markus ionization chamber 
is 0.033, 0.019, and 0.001, respectively.
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Maximum deviation of 18.5% was found with face-down orientation. The orientation (face-up 
or face-down) of the MOSkin detector must be taken into account when used for skin dose 
measurement. The MOSkin measurement is in close agreement with GAFCHROMIC EBT2 
film for the measurement made under the presence of wedges. 
MOSkin detector is suitable detector for in vivo skin dosimetry as compared to GAFCHROMIC 
EBT2 film because of its WED of 0.07 mm. However, due to the difference between the detec-
tor’s WED and materials, neither can be used as true benchmarked for determining MOSkin 
detector accuracy as skin dosimeter. Monte Carlo calculation may provide a true benchmark 
tool for this comparison. However, this is not within the scope of this study.
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